The Bosscher Foundation's aim is to promote scientific research into health related complaints attributed to the use of local anesthetics.

In particular, the Bosscher Foundation focuses its attention on the anesthetic, articaine hydrochloride, the active component in:

Ultracaine™ available in the Netherlands, Belgium, Germany and many other countries.
Septanest™ available in Canada, France, Spain and many other countries.
Citocain™ available in Italy, Spain, Russia and Japan.
Primacaine™ available in Italy, France, Russia, Poland and India.
Septocaine™ available in USA, Scandinavian countries and Russia.
Ubistesine™ available in Germany, The Netherlands, Belgium and many other countries.
Alphacaine™ available in France, Germany and many other countries

The Bosscher Foundation suspects that articaine is responsible for a series
of unexpected side effects.